Back to search
FDAFDA · Food and drugs·Recall number D-0734-2026

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Published August 5, 2026 · Recall initiated: July 2, 2026

Summary

FDA records drug Class II recall D-0734-2026, published August 5, 2026 and initiated July 2, 2026. Recalling firm: MYLAN PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 5688 vials; Lot: Lot #: 3241653, Exp 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of precipitate

What to do

Voluntary: Firm initiated · Letter

Get an email if MYCOPHENOLATE MOFETIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MYCOPHENOLATE MOFETIL
Manufacturer
MYLAN PHARMACEUTICALS INC
Distributor
USA Nationwide
Lot
Lot #: 3241653, Exp 4/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label). recalled?

Yes. FDA published recall D-0734-2026 on August 5, 2026. Reported hazard: Presence of precipitate

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MYCOPHENOLATE MOFETIL.